Animal Parasiticides Market Report 2026

The animal parasiticides market size has grown strongly in recent years. It will grow from $10.13 billion in 2025 to $10.92 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing livestock population, traditional farming practices, rising prevalence of parasitic infections, growing veterinary infrastructure, low awareness of preventive parasitic treatments.

The animal parasiticides market size is expected to see strong growth in the next few years. It will grow to $14.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to technological advancements in parasiticides, growing companion animal market, increasing regulatory support for animal health, rising adoption of preventive healthcare, expansion of veterinary services in emerging regions. Major trends in the forecast period include rising incidence of parasitic infestations in livestock, adoption of novel veterinary parasiticides formulations, increasing awareness of animal health and welfare, growth in companion animal ownership and care, integration of preventive healthcare practices in veterinary medicine.

The rising prevalence of zoonotic diseases is expected to drive the growth of the animal parasiticides market in the coming years. Zoonotic diseases are infectious conditions that can be transmitted between animals and humans and are caused by pathogens such as bacteria, viruses, parasites, or fungi. The incidence of zoonotic diseases is increasing due to factors including climate change, growing antibiotic resistance, inadequate sanitation, and poor hygiene practices. Animal parasiticides play a crucial role in preventing zoonotic diseases by controlling parasites that serve as vectors or reservoirs for disease transmission between animals and humans. For example, in December 2024, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, there were 148,181 reported human cases of campylobacteriosis, up from 139,225 in 2022, along with rising cases of salmonellosis and STEC infections, indicating a broader upward trend in zoonotic diseases. Veterinary services support this need by providing preventive care, diagnostics, and treatments for animals, thereby reducing transmission risks through vaccination programs, disease surveillance, and client education. Therefore, the increasing prevalence of zoonotic diseases is contributing to the growth of the animal parasiticides market.

Major companies operating in the animal parasiticides market are concentrating on the development of innovative combination therapies and advanced oral formulations to gain a competitive edge and address the rising demand for broad-spectrum parasite control. Combination therapies and advanced oral formulations are products that incorporate multiple active ingredients into a single, easy-to-administer dosage form, offering comprehensive and long-lasting protection against a wide range of parasites. For instance, in January 2025, Elanco Animal Health Incorporated, a U.S.-based global animal health company, launched Credelio Quattro, an innovative oral combination parasiticide designed to provide broad-spectrum parasite protection. Credelio Quattro combines four active ingredients - lotilaner, moxidectin, praziquantel, and pyrantel - into a single monthly chewable tablet that protects dogs against fleas, ticks, heartworms, roundworms, hookworms, and tapeworms, expanding beyond conventional single-agent treatments. This combination approach improves efficacy by targeting multiple parasite classes through different mechanisms of action, simplifies parasite management for veterinarians and pet owners, and enhances treatment adherence. With rapid onset and extended coverage, Credelio Quattro supports both preventive and therapeutic use while helping to limit the development of parasite resistance through comprehensive protection in a single formulation.

In April 2024, Merck & Co. Inc., a U.S.-based animal health pharmaceutical company, acquired Elanco Animal Health Incorporated’s Aqua Business for approximately $1.3 billion. Through this acquisition, Merck Animal Health sought to strengthen and expand its aquaculture portfolio by adding established parasiticide and health management solutions for farmed fish, thereby reinforcing its position in the global aquaculture animal health market. Elanco Animal Health Incorporated’s Aqua Business specializes in the development and commercialization of aquaculture products, including parasiticides for sea lice control, vaccines, and other health solutions for farmed fish species.

Major companies operating in the animal parasiticides market are Merck & Co. Inc., Bayer AG, Sanofi SA, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Inc., Ceva Sante Animale S.A., Virbac SA, Dechra Pharmaceuticals plc, Phibro Animal Health Corporation, Vetoquinol SA, Norbrook Laboratories Limited, Neogen Corporation, Indian Immunologicals Ltd., Krka dd Novo Mesto, Bimeda Inc., The Chanelle Group, ECO Animal Health Group plc, Zydus Animal Health and Investments Ltd., Kyoritsu Seiyaku Corporation.

North America was the largest region in the animal parasiticides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal parasiticides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal parasiticides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the animal parasiticides market by increasing the cost of imported active ingredients and formulations, leading to higher production expenses for manufacturers. These effects are most pronounced in regions heavily reliant on imports, such as North America and Europe, particularly for specialized endoparasiticides and ectoparasiticides. While tariffs may slow growth in certain segments, they have also incentivized local production and innovation in domestic markets, allowing manufacturers to develop cost-effective solutions and reduce dependency on international supply chains.

The animal parasiticides market research report is one of a series of new reports that provides animal parasiticides market statistics, including animal parasiticides industry global market size, regional shares, competitors with a animal parasiticides market share, detailed animal parasiticides market segments, market trends and opportunities, and any further data you may need to thrive in the animal parasiticides industry. This animal parasiticides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Animal parasiticides are chemical or biological agents used to prevent, control, and eliminate parasitic infestations in livestock, companion animals, and other domesticated species. These products help protect animals from internal and external parasites, improving overall health and enhancing productivity in agricultural and veterinary settings.

The primary types of animal parasiticides include endoparasiticides, ectoparasiticides, and endectocides. Endoparasiticides are medications formulated to eliminate internal parasites, such as worms, that live within an animal’s body. These parasiticides are used across various livestock, including swine, poultry, ovine, bovine, equine, canine, and feline species. They are administered in different settings, including veterinary clinics and hospitals, animal farms, and home care environments.

The animal parasiticides market consists of sales of injectable dewormers, feed additives and medicated pellets, sprays and pour-ons, and macrocyclic lactones. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.